Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietrich Kraft

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|November 5, 2002
From allergen structure to new forms of allergen-specific immunotherapyRudolf Valenta, Dietrich Kraft
Biomolecules|July 29, 2023
The History and Science of the Major Birch Pollen Allergen Bet v 1Heimo Breiteneder, Dietrich Kraft
International Archives of Allergy and Immunology|June 25, 2021
Homology of Two cDNAs Coding for Birch Pollen Allergens with Calmodulin: Protein-Bound Ca2+ Affects the IgE-Binding CapacitySusanne Seiberler, Otto Scheiner, Dietrich Kraft, et al.
European Journal of Immunology|February 6, 2002
Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanismsVerena Niederberger, Bodo Niggemann, Dietrich Kraft, et al.
Methods (San Diego, Calif.)|February 14, 2004
Strategies for converting allergens into hypoallergenic vaccine candidatesSusanne Vrtala, Margarete Focke-Tejkl, Ines Swoboda, et al.
International Archives of Allergy and Immunology|May 22, 2002
Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergyLili Kazemi-Shirazi, Verena Niederberger, Birgit Linhart, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 3, 2002
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicityBirgit Linhart, Beatrice Jahn-Schmid, Petra Verdino, et al.
Immunology|December 4, 2002
Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapyHans Grönlund, Susanne Vrtala, Ursula Wiedermann, et al.
European Journal of Immunology|September 5, 2002
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibodySabine Flicker, Peter Steinberger, Lars Norderhaug, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patientsMerima Bublin, Christian Radauer, Iain B H Wilson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|November 5, 2002
From allergen structure to new forms of allergen-specific immunotherapyRudolf Valenta, Dietrich Kraft
Biomolecules|July 29, 2023
The History and Science of the Major Birch Pollen Allergen Bet v 1Heimo Breiteneder, Dietrich Kraft
International Archives of Allergy and Immunology|June 25, 2021
Homology of Two cDNAs Coding for Birch Pollen Allergens with Calmodulin: Protein-Bound Ca2+ Affects the IgE-Binding CapacitySusanne Seiberler, Otto Scheiner, Dietrich Kraft, et al.
European Journal of Immunology|February 6, 2002
Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanismsVerena Niederberger, Bodo Niggemann, Dietrich Kraft, et al.
Methods (San Diego, Calif.)|February 14, 2004
Strategies for converting allergens into hypoallergenic vaccine candidatesSusanne Vrtala, Margarete Focke-Tejkl, Ines Swoboda, et al.
International Archives of Allergy and Immunology|May 22, 2002
Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergyLili Kazemi-Shirazi, Verena Niederberger, Birgit Linhart, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 3, 2002
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicityBirgit Linhart, Beatrice Jahn-Schmid, Petra Verdino, et al.
Immunology|December 4, 2002
Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapyHans Grönlund, Susanne Vrtala, Ursula Wiedermann, et al.
European Journal of Immunology|September 5, 2002
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibodySabine Flicker, Peter Steinberger, Lars Norderhaug, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patientsMerima Bublin, Christian Radauer, Iain B H Wilson, et al.
Pageof 2